{"transactions":[{"id":1470484,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-24T20:29:48.000Z","date":"2024-06-21","kind":"purchase","planned":false,"acquired":true,"shares":115000,"price":0.2671,"value":30716.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $0.2579 to $0.27 per share, with a weighted average purchase price of $0.2671 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":680403,"source":{"system":"sec-edgar","filing":"0001415889-24-017978","document":"form4-06242024_080643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000141588924017978/form4-06242024_080643.xml","form_type":"4"}},{"id":1470483,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-24T20:29:48.000Z","date":"2024-06-20","kind":"purchase","planned":false,"acquired":true,"shares":190000,"price":0.2532,"value":48108.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $0.24 to $0.2594 per share, with a weighted average purchase price of $0.2532 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":565403,"source":{"system":"sec-edgar","filing":"0001415889-24-017978","document":"form4-06242024_080643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000141588924017978/form4-06242024_080643.xml","form_type":"4"}},{"id":1677630,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-17T21:05:20.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option will vest on January 12, 2025 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":3.11,"expiration_date":"2034-01-11","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-24-001740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919124001740/doc4.xml","form_type":"4"}},{"id":1773839,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-25T20:21:40.000Z","date":"2023-09-22","kind":"purchase","planned":false,"acquired":true,"shares":30403,"price":1.38,"value":41956.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.37 to $1.40 per share, with a weighted average purchase price of $1.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":375403,"source":{"system":"sec-edgar","filing":"0001209191-23-050476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123050476/doc4.xml","form_type":"4"}},{"id":1773838,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-25T20:21:40.000Z","date":"2023-09-21","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":1.38,"value":48300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.35 to $1.40 per share, with a weighted average purchase price of $1.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":345000,"source":{"system":"sec-edgar","filing":"0001209191-23-050476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123050476/doc4.xml","form_type":"4"}},{"id":2049501,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:02:04.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":244800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option will vest on January 19, 2024 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date."}],"balance_after":244800,"derivative":{"exercise_price":2.55,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":244800},"source":{"system":"sec-edgar","filing":"0001209191-23-004212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123004212/doc4.xml","form_type":"4"}},{"id":2076011,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-27T23:41:33.000Z","date":"2022-12-22","kind":"purchase","acquired":true,"shares":110000,"price":2.25,"value":247500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $2.20 to $2.25 per share, with a weighted average purchase price of $2.25 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":310000,"source":{"system":"sec-edgar","filing":"0001209191-22-062741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122062741/doc4.xml","form_type":"4"}},{"id":2114310,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-16T21:26:18.000Z","date":"2022-11-15","kind":"purchase","acquired":true,"shares":100000,"price":1.66,"value":166000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.52 to $1.75 per share, with a weighted average purchase price of $1.66 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001209191-22-057314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122057314/doc4.xml","form_type":"4"}},{"id":2114309,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-16T21:26:18.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":100000,"price":1.43,"value":143000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.31 to $1.55 per share, with a weighted average purchase price of $1.43 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-22-057314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122057314/doc4.xml","form_type":"4"}},{"id":2164031,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":89584,"kind":"person","name":"Rock Edwin","position":1,"cik":"0001945417","reported_name":"Rock Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2022-09-07T20:10:14.000Z","date":"2022-09-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option will vest on September 2, 2023 and the remaining underlying shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":0.74,"expiration_date":"2032-09-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-22-048996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122048996/doc4.xml","form_type":"4"}}]}